Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 10-1996 | 07-1996 | 04-1996 | 01-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -760 | 3,763 | 0 | N/A | N/A |
| Depreciation Amortization | 15 | 4,731 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 33 | N/A | N/A | N/A | N/A |
| Other Working Capital | 68 | -3,258 | 0 | N/A | N/A |
| Other Operating Activity | 87 | -1,060 | 0 | 0 | 0 |
| Operating Cash Flow | $-557 | $4,176 | $0 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -17,813 | 0 | N/A | N/A |
| Other Investing Activity | 0 | -3,159 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $-20,972 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 300 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 977 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -122 | 17,655 | 0 | 0 | 0 |
| Financing Cash Flow | $1,155 | $17,655 | $0 | $N/A | $N/A |
| Beginning Cash Position | 111 | 2,025 | 0 | N/A | N/A |
| End Cash Position | 709 | 2,884 | 0 | N/A | N/A |
| Net Cash Flow | $598 | $859 | $0 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -557 | 4,176 | 0 | N/A | N/A |
| Free Cash Flow | -557 | 4,176 | 0 | 0 | 0 |